Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.015 CAD -25%
Market Cap: 954.8k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Replicel Life Sciences Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Replicel Life Sciences Inc
Research & Development Peer Comparison

Comparables:
ABCL
ARCH
IOT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Replicel Life Sciences Inc
XTSX:RP
Research & Development
-CA$514.3k
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
7%
Abcellera Biologics Inc
NASDAQ:ABCL
Research & Development
-$175.7m
CAGR 3-Years
-81%
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Research & Development
-CA$5.2m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
-54%
Innovotech Inc
XTSX:IOT
Research & Development
-CA$235.6k
CAGR 3-Years
-92%
CAGR 5-Years
-49%
CAGR 10-Years
7%

See Also

What is Replicel Life Sciences Inc's Research & Development?
Research & Development
-514.3k CAD

Based on the financial report for Sep 30, 2023, Replicel Life Sciences Inc's Research & Development amounts to -514.3k CAD.

What is Replicel Life Sciences Inc's Research & Development growth rate?
Research & Development CAGR 10Y
7%

Over the last year, the Research & Development growth was 19%.

Back to Top